Nan Ni , Zhiming Jiang , Quanzhen Wang , Xiaoxu Ren , Xuebin Tian , Lifeng Yu
{"title":"Altered gut microbiota composition and its clinical correlations in patients with severe pneumonia: a single-center observational study in China","authors":"Nan Ni , Zhiming Jiang , Quanzhen Wang , Xiaoxu Ren , Xuebin Tian , Lifeng Yu","doi":"10.1016/j.micpath.2025.108059","DOIUrl":null,"url":null,"abstract":"<div><div>Severe pneumonia in intensive care unit (ICU) patients is frequently accompanied by alterations in the gut microbiota. To explore the characteristics of the gut microbiota in these patients, we conducted an observational study comparing 38 patients with severe pneumonia to 34 healthy participants. We used 16S rRNA gene sequencing to profile their gut microbiota and analyze its correlation with clinical parameters. Our results show a significant dysbiosis in the gut microbiota of severe pneumonia patients, characterized by reduced diversity and notable shifts in microbial composition. Specifically, the study revealed an increase in potentially harmful bacteria like <em>Enterococcus</em> and a decrease in potentially beneficial bacteria such as <em>Megamonas</em> and <em>Faecalibacterium</em>. Functional analysis showed an upregulation of pathways for <em>Staphylococcus aureus</em> infection and valine, leucine, and isoleucine degradation in the severe pneumonia group compared to the healthy control group. Furthermore, our analysis found positive correlations between certain bacteria and clinical indicators. <em>Megamonas</em> abundance correlated positively with prealbumin levels, a marker of nutritional status. <em>Bifidobacterium</em> showed a positive correlation with white blood cell (WBC) count, and <em>Blautia</em> was positively correlated with the duration of mechanical ventilation. These findings suggest that gut microbiota dysbiosis may play a role in the progression of severe pneumonia, highlighting the potential for targeted therapies in this patient population.</div></div>","PeriodicalId":18599,"journal":{"name":"Microbial pathogenesis","volume":"209 ","pages":"Article 108059"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial pathogenesis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0882401025007843","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Severe pneumonia in intensive care unit (ICU) patients is frequently accompanied by alterations in the gut microbiota. To explore the characteristics of the gut microbiota in these patients, we conducted an observational study comparing 38 patients with severe pneumonia to 34 healthy participants. We used 16S rRNA gene sequencing to profile their gut microbiota and analyze its correlation with clinical parameters. Our results show a significant dysbiosis in the gut microbiota of severe pneumonia patients, characterized by reduced diversity and notable shifts in microbial composition. Specifically, the study revealed an increase in potentially harmful bacteria like Enterococcus and a decrease in potentially beneficial bacteria such as Megamonas and Faecalibacterium. Functional analysis showed an upregulation of pathways for Staphylococcus aureus infection and valine, leucine, and isoleucine degradation in the severe pneumonia group compared to the healthy control group. Furthermore, our analysis found positive correlations between certain bacteria and clinical indicators. Megamonas abundance correlated positively with prealbumin levels, a marker of nutritional status. Bifidobacterium showed a positive correlation with white blood cell (WBC) count, and Blautia was positively correlated with the duration of mechanical ventilation. These findings suggest that gut microbiota dysbiosis may play a role in the progression of severe pneumonia, highlighting the potential for targeted therapies in this patient population.
期刊介绍:
Microbial Pathogenesis publishes original contributions and reviews about the molecular and cellular mechanisms of infectious diseases. It covers microbiology, host-pathogen interaction and immunology related to infectious agents, including bacteria, fungi, viruses and protozoa. It also accepts papers in the field of clinical microbiology, with the exception of case reports.
Research Areas Include:
-Pathogenesis
-Virulence factors
-Host susceptibility or resistance
-Immune mechanisms
-Identification, cloning and sequencing of relevant genes
-Genetic studies
-Viruses, prokaryotic organisms and protozoa
-Microbiota
-Systems biology related to infectious diseases
-Targets for vaccine design (pre-clinical studies)